6α-Methyl-17α-bromoprogesterone
From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Boghog (talk | contribs) at 19:25, 11 September 2020 (templated cites). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Clinical data | |
---|---|
Other names | 6α-Methyl-17α-bromopregn-4-en-3,20-dione |
Chemical and physical data | |
Formula | C22H31BrO2 |
Molar mass | 407.392 g·mol−1 |
3D model (JSmol) | |
| |
|
6α-Methyl-17α-bromoprogesterone is a steroidal progestin related to haloprogesterone (6α-fluoro-17α-bromoprogesterone) that was described in 1963 and was never marketed.[1]
See also
References
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 179–. ISBN 978-1-4757-2085-3.
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All stub articles